12:00 AM
Nov 15, 1999
 |  BC Week In Review  |  Company News  |  Deals

ViroLogic, Bristol-Myers deal

Bristol-Myers will use ViroLogic’s PhenoSense HIV phenotypic drug susceptibility assay to determine HIV susceptibility profiles of...

Read the full 59 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >